- Home
- GLW vs EW Comparison
GLW vs EW Comparison
Compare GLW & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLW
- EW
- Stock Information
- Founded
- GLW 1851
- EW 1958
- Country
- GLW United States
- EW United States
- Employees
- GLW N/A
- EW N/A
- Industry
- GLW Telecommunications Equipment
- EW Industrial Specialties
- Sector
- GLW Industrials
- EW Health Care
- Exchange
- GLW Nasdaq
- EW Nasdaq
- Market Cap
- GLW 44.4B
- EW 45.5B
- IPO Year
- GLW N/A
- EW 2000
- Fundamental
- Price
- GLW $78.71
- EW $75.10
- Analyst Decision
- GLW Strong Buy
- EW Buy
- Analyst Count
- GLW 13
- EW 19
- Target Price
- GLW $66.75
- EW $85.74
- AVG Volume (30 Days)
- GLW 8.6M
- EW 3.9M
- Earning Date
- GLW 10-28-2025
- EW 10-23-2025
- Dividend Yield
- GLW 1.42%
- EW N/A
- EPS Growth
- GLW 83.78
- EW 188.09
- EPS
- GLW 0.94
- EW 7.02
- Revenue
- GLW $14,206,000,000.00
- EW $5,685,100,000.00
- Revenue This Year
- GLW $24.39
- EW $13.25
- Revenue Next Year
- GLW $8.44
- EW $9.76
- P/E Ratio
- GLW $83.89
- EW $10.72
- Revenue Growth
- GLW 14.63
- EW 9.14
- 52 Week Low
- GLW $37.31
- EW $64.01
- 52 Week High
- GLW $78.75
- EW $83.00
- Technical
- Relative Strength Index (RSI)
- GLW 87.50
- EW 28.13
- Support Level
- GLW $66.14
- EW $80.08
- Resistance Level
- GLW $69.29
- EW $78.10
- Average True Range (ATR)
- GLW 1.80
- EW 1.48
- MACD
- GLW 0.65
- EW -0.72
- Stochastic Oscillator
- GLW 99.25
- EW 2.63
About GLW Corning Incorporated
Corning is a leader in materials science, specializing in the production of glass, ceramics, and optical fiber. The firm supplies its products for a wide range of applications, from flat-panel displays in televisions to gasoline particulate filters in automobiles to optical fiber for broadband access, with a leading share in many of its end markets.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.